News

Octapharma improves people's health - and relieves the electricity grid

December 19, 2022
Octapharma's facility will soon start producing its first kWh. Photo: SBP
Octapharma's facility will soon start producing its first kWh. Photo: SBP
Octapharma is a leading company in pharmacology and works daily for people's health. Now they are also contributing to society by strengthening the country's electricity grid with the help of a solar power plant.

In Arlandastad, a few stone's throws from the airport north of Stockholm, Octapharma's logistics center has been located since 2014. According to Johan Braunerhielm, project manager at SBP, there was a great desire internally at the pharmacology giant to operate part of its business on solar energy.
– It is noticeable that the interest in green investments permeates the entire organization, and then it is particularly fun in my role to be able to deliver a facility, he says.

The project comprises a 493 kW facility, which corresponds to almost 100 villa installations and is estimated to give an annual production of approximately 421,000 kilowatt hours.
– The project has gone very well from start to finish and a big reason for that I want to dedicate to our relations at Octapharma, which clearly shows that they have top-class routine in the client role. For me, it is a pure pleasure to be able to act in my role in collaboration with such a humble and solution-oriented customer, and who also has a consistent view on how the project is carried out in everything from sustainable guidelines to technology choices with high security in focus, says Johan Braunerhielm.

The company was founded in Switzerland in 1983 and has since grown to become a leading player in blood plasma and thus works to improve people's health.
– There was a security in how SBP presented and calculated on the facility right from the first dialogue. It gave great confidence. Then I think that the project was delivered exactly as promised from start to finish and everyone who worked on the project from our side was satisfied with the implementation, says Mats Julin at Octapharma.

More news about green technology

Back to News